These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28598322)

  • 21. Rheumatoid factor seropositivity and rheumatoid symptoms in coal worker's pneumoconiosis.
    Kart L; Sarikaya S; Gurel A; Altin R; Armutcu F; Tor M; Ozdolap S
    Clin Rheumatol; 2003 Oct; 22(4-5):365-6. PubMed ID: 14577001
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in early diagnosis of rheumatoid arthritis].
    Kondo H; Sakai M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():289-92. PubMed ID: 15799363
    [No Abstract]   [Full Text] [Related]  

  • 26. Performance of the 2010 Rheumatoid Arthritis Classification Criteria.
    Davatchi F; Abari IS; Soroosh S; Soroosh M; Sadeghi Abdollahi B
    Int J Rheum Dis; 2012 Oct; 15(5):455-61. PubMed ID: 23083035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative.
    de Punder YM; Hendrikx J; den Broeder AA; Valls Pascual E; van Riel PL; Fransen J
    J Rheumatol; 2013 Aug; 40(8):1268-74. PubMed ID: 23729803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value of some serological markers of rheumatoid arthritis in assessment of x-ray outcome of the disease].
    Redaĭtene E; Stropuvene S; Dadonene I; Kidraĭte G; Lapinene G
    Ter Arkh; 2006; 78(12):67-70. PubMed ID: 17294867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
    Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
    J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RF latex and anti-CCP antibodies: a combined strategy for diagnosing RA in primary care?
    Steuer A; Watkins J; Smith F; Day L; Demetriadi F; Chapel H
    Rheumatology (Oxford); 2008 Mar; 47(3):375-6. PubMed ID: 18234710
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis.
    Sun J; Zhang Y; Liu L; Liu G
    Clin Exp Rheumatol; 2014; 32(1):11-21. PubMed ID: 24050751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis.
    Emad Y; Shehata M; Ragab Y; Saad A; Hamza H; Abou-Zeid A
    Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiologic and functional aspects of rheumatoid arthritis in patients attending the Hospital Rehabilitation Clinic in Iasi, Romania].
    Costea AI; Ancuţa C; Chirieac R
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1219-24. PubMed ID: 22276473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevant incidence of cervical arthritis in patients with erosive seropositive rheumatoid arthritis even today.
    Hagenow A; Seifert J; Zeissig A; Conrad K; Kleymann A; Aringer M
    Clin Exp Rheumatol; 2013; 31(2):213-8. PubMed ID: 23295192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
    Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.